BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen ZM, Crone KG, Watson MA, Pfeifer JD, Wang HL. Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma. Am J Surg Pathol 2005;29:1600-8. [PMID: 16327432 DOI: 10.1097/01.pas.0000176426.21876.a5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Skawran B, Steinemann D, Weigmann A, Flemming P, Becker T, Flik J, Kreipe H, Schlegelberger B, Wilkens L. Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. Mod Pathol 2008;21:505-16. [PMID: 18277965 DOI: 10.1038/modpathol.3800998] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
2 Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: Implications for imaging and management. Radiology. 2011;258:673-693. [PMID: 21339346 DOI: 10.1148/radiol.10100376] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
3 Marquardt JU, Quasdorff M, Varnholt H, Curth HM, Mesghenna S, Protzer U, Goeser T, Nierhoff D. Neighbor of Punc E11, a novel oncofetal marker for hepatocellular carcinoma. Int J Cancer. 2011;128:2353-2363. [PMID: 20658536 DOI: 10.1002/ijc.25567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
4 Chan KY, Lai PB, Squire JA, Beheshti B, Wong NL, Sy SM, Wong N. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod Pathol 2006;19:1546-54. [DOI: 10.1038/modpathol.3800674] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
5 Shafizadeh N, Kakar S. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv Anat Pathol. 2011;18:438-445. [PMID: 21993269 DOI: 10.1097/pap.0b013e318234abb4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
6 Kok NF, Terkivatan T, Ijzermans JN. Regarding 'Liver cell adenoma and liver cell adenomatosis' by Ludger Barthelmes and Iain S. Tait. HPB (Oxford) 2006;8:71-2. [PMID: 18333245 DOI: 10.1080/13651820500537879] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kahn ME, French S, Wang HL. Hepatocellular Adenoma: Morphological and Molecular Variants and Distinction From Well-Differentiated Hepatocellular Carcinoma. Pathology Case Reviews 2009;14:13-20. [DOI: 10.1097/pcr.0b013e31819c4956] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
8 Jones A, Kroneman TN, Blahnik AJ, Graham RP, Mounajjed T, Torbenson MS, Moreira RK. Ki-67 "hot spot" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas. Virchows Arch 2021;478:201-7. [PMID: 32583014 DOI: 10.1007/s00428-020-02868-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Sun Y, Li W, Shen S, Yang X, Lu B, Zhang X, Lu P, Shen Y, Ji J. Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis. J Transl Med 2019;17:390. [PMID: 31771612 DOI: 10.1186/s12967-019-02138-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6:347-362. [PMID: 25790815 DOI: 10.1007/s13244-015-0399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
11 Lai JP, Chen ZM, Lok T, Chan OT, Himmelfarb E, Zhai Q, Lin F, Wang HL. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions. J Clin Pathol 2014;67:464-9. [PMID: 24407433 DOI: 10.1136/jclinpath-2013-201907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
12 Li Y, Liu F, Zhou W, Zhang S, Chu P, Lin F, Wang HL. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma. Diagn Pathol 2020;15:127. [PMID: 33054843 DOI: 10.1186/s13000-020-01041-8] [Reference Citation Analysis]
13 Witjes CD, ten Kate FJ, Verhoef C, de Man RA, IJzermans JN. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers. J Clin Pathol. 2013;66:687-691. [PMID: 23585667 DOI: 10.1136/jclinpath-2012-201156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]